Allaura S Cone1, Sara B York1, David G Meckes1. 1. Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA.
Abstract
PURPOSE OF REVIEW: Epstein-Barr virus (EBV) is a known determinant for numerous malignancies and may contribute to autoimmune diseases. The underlining mechanisms behind EBV pathologies is not completely understood. Recently, extracellular vesicles (EVs) released from infected cells have been found to produce profound effects on cellular microenvironments. Therefore, in this review we sought to critically evaluate the roles of EVs in EBV pathogenesis and assess their potential therapeutic and diagnostic utility. RECENT FINDINGS: EBV-altered EVs are capable of activating signaling cascades and phenotypic changes in recipient cells through the transfer of viral proteins and RNAs. Moreover, several EV-associated microRNAs have encouraging prognostic or diagnostic potential in EBV-associated cancers. SUMMARY: Current evidence suggests that EBV-modified EVs affect viral pathogenesis and cancer progression. However, further research is needed to investigate the direct role of both viral and host products on recipient cells and the mechanisms driving viral protein and RNA EV packaging and content modification.
PURPOSE OF REVIEW: Epstein-Barr virus (EBV) is a known determinant for numerous malignancies and may contribute to autoimmune diseases. The underlining mechanisms behind EBV pathologies is not completely understood. Recently, extracellular vesicles (EVs) released from infected cells have been found to produce profound effects on cellular microenvironments. Therefore, in this review we sought to critically evaluate the roles of EVs in EBV pathogenesis and assess their potential therapeutic and diagnostic utility. RECENT FINDINGS: EBV-altered EVs are capable of activating signaling cascades and phenotypic changes in recipient cells through the transfer of viral proteins and RNAs. Moreover, several EV-associated microRNAs have encouraging prognostic or diagnostic potential in EBV-associated cancers. SUMMARY: Current evidence suggests that EBV-modified EVs affect viral pathogenesis and cancer progression. However, further research is needed to investigate the direct role of both viral and host products on recipient cells and the mechanisms driving viral protein and RNA EV packaging and content modification.
Authors: Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger Journal: Nat Immunol Date: 2002-09-03 Impact factor: 25.606
Authors: Do Nyun Kim; Min Koo Seo; Hoyun Choi; Su Yeon Kim; Hee Jong Shin; A-Ran Yoon; Qian Tao; Sun Young Rha; Suk Kyeong Lee Journal: J Gen Virol Date: 2012-11-21 Impact factor: 3.891
Authors: Ali Afrasiabi; Grant P Parnell; Nicole Fewings; Stephen D Schibeci; Monica A Basuki; Ramya Chandramohan; Yuan Zhou; Bruce Taylor; David A Brown; Sanjay Swaminathan; Fiona C McKay; Graeme J Stewart; David R Booth Journal: Genome Med Date: 2019-04-30 Impact factor: 11.117
Authors: Víctor Acevedo-Sánchez; Ruth M Rodríguez-Hernández; Sergio R Aguilar-Ruíz; Honorio Torres-Aguilar; María de Los A Romero-Tlalolini Journal: Membranes (Basel) Date: 2021-06-20